Difficulty: Medium
Average Score: 93%
Practice
The patient underwent an allograft renal transplant 48 hours earlier and is showing signs of rejection. What drug would the nurse expect the physician to order?
Correct answer
A
Rationale
The correct answer is A: Muromonab. Muromonab is a monoclonal antibody that targets T cells, suppressing the immune response and preventing rejection in organ transplant patients. It is used for acute rejection episodes.
B: Anakinra is an interleukin-1 receptor antagonist used for autoimmune diseases, not transplant rejection.
C: Mycophenolate is an immunosuppressive drug used for maintenance therapy in transplant patients but not for acute rejection.
D: Sirolimus is an mTOR inhibitor used for maintenance immunosuppression, not for acute rejection.
B: Anakinra is an interleukin-1 receptor antagonist used for autoimmune diseases, not transplant rejection.
C: Mycophenolate is an immunosuppressive drug used for maintenance therapy in transplant patients but not for acute rejection.
D: Sirolimus is an mTOR inhibitor used for maintenance immunosuppression, not for acute rejection.